Propiedad y actividad de insiders de Prime Medicine, Inc. (PRME): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $3.00 |
| Capitalización | $542M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-06-05 | Schenkein David P | A-Award | 75,000 | $230K |
| 2026-06-05 | Marrazzo Jeffrey D | A-Award | 75,000 | $230K |
| 2026-06-05 | NELSEN ROBERT | A-Award | 75,000 | $230K |
| 2026-06-05 | Kelly Michael Aaron | A-Award | 75,000 | $230K |
| 2026-06-05 | Foster-Cheek Kaye I | A-Award | 75,000 | $230K |
| 2026-06-05 | Chung Wendy | A-Award | 75,000 | $230K |
| 2026-06-05 | Cahill Thomas | A-Award | 75,000 | $230K |
| 2026-04-16 | Makhni Svetlana Ni | A-Award | 800,000 | $2.9M |
| 2026-04-16 | Makhni Svetlana Ni | |||
| 2026-02-26 | Reine Allan | A-Award | 1,300,000 | $5.7M |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $8.6M | $37.0M | $185.4M | $187.6M | $41.6M | $182.5M | $63.0M |
| Inversiones a Corto | 0 | $16.4M | $84.2M | $106.3M | $80.1M | $8.0M | $114.6M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $8.7M | $53.4M | $270.6M | $296.6M | $143.0M | $211.9M | $181.3M |
| Inmovilizado Material | 0 | $596000 | $15.7M | $48.6M | $36.6M | $71.6M | $146.7M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $8.7M | $54.8M | $301.9M | $360.3M | $193.9M | $297.5M | $342.7M |
| Cuentas por Pagar | 0 | $250000 | $1.4M | $4.3M | $19.5M | $11.4M | $8.9M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $7.3M | $19.4M | $58.0M | $26.7M | $56.4M | $38.0M | $37.4M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | $108.3M |
| Pasivos Totales | $7.3M | $21.3M | $62.3M | $44.0M | $60.8M | $144.4M | $221.9M |
| Reservas | -$2.6M | -$6.0M | -$171.4M | -$293.2M | -$491.3M | -$687.2M | -$888.4M |
| Patrimonio Neto | $1.4M | $33.5M | $239.6M | $316.3M | $133.1M | $153.1M | $120.9M |
| Deuda Total | 0 | 0 | $10.4M | $28.7M | $13.6M | $40.8M | $116.4M |
| Deuda Neta | -$8.6M | -$53.3M | -$259.2M | -$265.2M | -$108.0M | -$149.6M | -$61.3M |
| Capital Circulante | $1.4M | $34.0M | $212.6M | $269.9M | $86.6M | $173.9M | $143.8M |
Salud financiera
| Deuda / Patrimonio | 2.83 |
| Ratio corriente | 3.05 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -3.72 |
Rentabilidad
| Rentabilidad sobre capital | -188.27% |
| Rentabilidad sobre capital invertido | -86.83% |
| Rentabilidad sobre activos | -75.45% |
| Margen bruto | -1025.61% |
| Margen operativo | -4824.94% |
| Margen neto | -4613.11% |
Empresas relacionadas: BCAX · EYPT · KURA · MRVI · PROK · REPL · RZLT
Explorar sector: Healthcare · Biotechnology
Más secciones de PRME: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones